dc.contributor.author | Littlejohns, Thomas J. | |
dc.contributor.author | Henley, William E. | |
dc.contributor.author | Lang, IA | |
dc.contributor.author | Annweiler, Cedric | |
dc.contributor.author | Beauchet, Olivier | |
dc.contributor.author | Chaves, Paolo H.M. | |
dc.contributor.author | Fried, Linda | |
dc.contributor.author | Kestenbaum, Bryan R. | |
dc.contributor.author | Kuller, Lewis H. | |
dc.contributor.author | Langa, KM | |
dc.contributor.author | Lopez, Oscar L. | |
dc.contributor.author | Kos, Katarina | |
dc.contributor.author | Soni, Maya | |
dc.contributor.author | Llewellyn, DJ | |
dc.date.accessioned | 2016-02-19T10:58:13Z | |
dc.date.issued | 2014-09-02 | |
dc.description.abstract | OBJECTIVE: To determine whether low vitamin D concentrations are associated with an increased risk of incident all-cause dementia and Alzheimer disease. METHODS: One thousand six hundred fifty-eight elderly ambulatory adults free from dementia, cardiovascular disease, and stroke who participated in the US population-based Cardiovascular Health Study between 1992-1993 and 1999 were included. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were determined by liquid chromatography-tandem mass spectrometry from blood samples collected in 1992-1993. Incident all-cause dementia and Alzheimer disease status were assessed during follow-up using National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria. RESULTS: During a mean follow-up of 5.6 years, 171 participants developed all-cause dementia, including 102 cases of Alzheimer disease. Using Cox proportional hazards models, the multivariate adjusted hazard ratios (95% confidence interval [CI]) for incident all-cause dementia in participants who were severely 25(OH)D deficient (<25 nmol/L) and deficient (≥25 to <50 nmol/L) were 2.25 (95% CI: 1.23-4.13) and 1.53 (95% CI: 1.06-2.21) compared to participants with sufficient concentrations (≥50 nmol/L). The multivariate adjusted hazard ratios for incident Alzheimer disease in participants who were severely 25(OH)D deficient and deficient compared to participants with sufficient concentrations were 2.22 (95% CI: 1.02-4.83) and 1.69 (95% CI: 1.06-2.69). In multivariate adjusted penalized smoothing spline plots, the risk of all-cause dementia and Alzheimer disease markedly increased below a threshold of 50 nmol/L. CONCLUSION: Our results confirm that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease. This adds to the ongoing debate about the role of vitamin D in nonskeletal conditions. | en_GB |
dc.description.sponsorship | National Heart, Lung, and Blood Institute | en_GB |
dc.description.sponsorship | National Institute of Neurological Disorders and Stroke | en_GB |
dc.description.sponsorship | National Institute on Aging | en_GB |
dc.description.sponsorship | Alzheimer's Association | en_GB |
dc.description.sponsorship | Mary Kinross Charitable Trust | en_GB |
dc.description.sponsorship | James Tudor Foundation | en_GB |
dc.description.sponsorship | Halpin Trust | en_GB |
dc.description.sponsorship | Age Related Diseases and Health Trust | en_GB |
dc.description.sponsorship | Norman Family Charitable Trust | en_GB |
dc.description.sponsorship | UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula | en_GB |
dc.identifier.citation | Vol. 83 (10), pp. 920 - 928 | en_GB |
dc.identifier.doi | 10.1212/WNL.0000000000000755 | |
dc.identifier.grantnumber | HHSN268201200036C | en_GB |
dc.identifier.grantnumber | HHSN268200800007C | en_GB |
dc.identifier.grantnumber | N01HC55222 | en_GB |
dc.identifier.grantnumber | N01HC85079 | en_GB |
dc.identifier.grantnumber | N01HC85080 | en_GB |
dc.identifier.grantnumber | N01HC85081 | en_GB |
dc.identifier.grantnumber | N01HC85082 | en_GB |
dc.identifier.grantnumber | N01HC85083 | en_GB |
dc.identifier.grantnumber | N01HC85086 | en_GB |
dc.identifier.grantnumber | HL080295 | en_GB |
dc.identifier.grantnumber | AG023629 | en_GB |
dc.identifier.grantnumber | AG20098 | en_GB |
dc.identifier.grantnumber | AG15928 | en_GB |
dc.identifier.grantnumber | HL084443 | en_GB |
dc.identifier.grantnumber | NIRG-11-200737 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/19962 | |
dc.language.iso | en | en_GB |
dc.publisher | American Academy of Neurology (AAN) / Lippincott, Williams & Wilkins | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/25098535 | en_GB |
dc.rights | This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. | en_GB |
dc.subject | Aged | en_GB |
dc.subject | Alzheimer Disease | en_GB |
dc.subject | Dementia | en_GB |
dc.subject | Female | en_GB |
dc.subject | Follow-Up Studies | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Incidence | en_GB |
dc.subject | Male | en_GB |
dc.subject | Proportional Hazards Models | en_GB |
dc.subject | Risk Factors | en_GB |
dc.subject | United States | en_GB |
dc.subject | Vitamin D | en_GB |
dc.subject | Vitamin D Deficiency | en_GB |
dc.title | Vitamin D and the risk of dementia and Alzheimer disease | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2016-02-19T10:58:13Z | |
dc.identifier.issn | 0028-3878 | |
exeter.place-of-publication | United States | |
dc.identifier.eissn | 1526-632X | |
dc.identifier.journal | Neurology | en_GB |